Blockchain announcements

Protect Pharmaceutical Product Integrity with the Pharmaceutical Utility Network

Share this post:

drug store

The Drug Supply Chain Security Act (DSCSA) Interoperability Pilot demonstrates how blockchain technology can be used to effectively track and trace certain prescription drugs throughout the supply chain. The visibility offered by blockchain makes it easier for pharmaceutical supply chain actors to comply with with the DSCSA (a U.S. law that goes into effect in 2024), prevent the distribution of counterfeit drugs, facilitate the drug recall process and more.

In December 2019, KPMG, Merck, Walmart and IBM completed the Drug Supply Chain Security Act (DSCSA) Interoperability Pilot as part of the U.S. Food and Drug Administration (FDA) DSCSA Pilot Project Program. The pilot’s findings demonstrate that leveraging blockchain technology can significantly reduce the time needed to trace a prescription drug — from up to 16 weeks to two seconds.

 

The current state of healthcare and the DSCSA

The healthcare industry continues to change rapidly, but its legacy issues remain and manifest in new ways. Though more information is available and accessible than ever before, counterfeiting continues to plague the industry.

These are but a subset of the issues that healthcare supply chains face in the context of rapid urbanization, aging global populations and increasing cost pressures.

The Drug Supply Chain Security Act (DSCSA), which was enacted in 2013 by the FDA and will be implemented in phases over the next decade, reflects the U.S. government’s increasing focus on these challenges and the essential need for visibility into the end-to-end pharmaceutical supply chain. The law requires supply chain stakeholders to digitally track and trace certain prescription drugs and their distribution within the U.S.

 

medical records

 

supply chain fact1supply chain fact2

 

 

 

The FDA DSCSA Interoperability Pilot

IBM and its partners completed work for the FDA Drug Supply Chain Security Act (DSCSA) Interoperability Pilot, and aim to formally launch and scale the blockchain-enabled solution to streamline and facilitate DSCSA compliance for pharmaceutical supply chain stakeholders. To comply with the DSCSA, organizations must be able to digitally verify a drug product and its journey through the end-to-end supply chain. The pilot application uses blockchain technology to digitally store pharmaceutical product profiles and track and trace products at the serialized unit level from the point of manufacture to the point of dispense.

In addition to supply chain visibility, the pilot leverages blockchain to strengthen the protection of patients and patient safety. The application allows users the ability to quickly and effectively identify, investigate, and communicate about a relevant suspect or illegitimate drug product. This eliminates data siloes between supply chain actors and has strong potential to improve and expedite the drug recall process.

user benefits

 

Learn more about the FDA DSCSA Interoperability Pilot:

  • gov: DSCSA Pilot Project Program
  • IBM News Room: IBM, KPMG, Merck and Walmart to collaborate as part of FDA’s program to evaluate the use of blockchain to protect pharmaceutical product integrity
  • TechCrunch: IBM, KPMG, Merck, Walmart team up for drug supply chain blockchain pilot
  • Forbes: Merck and Walmart Will Track Prescription Drugs On IBM Blockchain In FDA Pilot
  • Reuters: IBM, Walmart, Merck in blockchain collaboration with FDA

 

Learn why IBM is the top-ranked blockchain for business services provider

Managing Editor

More Blockchain announcements stories

Blockchain newsletter for March: Exploring blockchain and interoperability

Moderna and IBM plan to collaborate on smarter COVID-19 vaccine management. Initial focus is on IBM Blockchain capabilities in end-to-end vaccine traceability in the supply chain and the IBM Digital Health Pass. IBM Digital Health Pass is the technology behind New York State’s Excelsior Pass, successfully piloted at Barclays Center and Madison Square Garden. Would […]

Continue reading

Blockchain Newsletter for February: Sustainability, COVID-19, crypto and digital events

Of the 96 companies that have been included in the Forbes Blockchain 50 since 2019, only 12 have made the list for all three years — including IBM. Three other 2021 listees have partnered with IBM for their claims to Forbes fame. A.P. Moller-Maersk made the list for TradeLens, the international shipping platform co-created with […]

Continue reading

Disrupting the patent ecosystem with blockchain and AI

Intellectual property is becoming one of the most valuable asset classes on the planet, with the pace of innovation being the ultimate competitive advantage across global technology sectors. Patents are one of the least understood and least effectively deployed asset classes. Intangible assets — which according to US research firms now represent more than 84 […]

Continue reading